Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 825.70
+12.75 (1.57%)
At close: Oct 16, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 204.61 billion as of October 16, 2026. It is the 6,406th most valuable company in the world and the 373rd biggest in India. Its market cap has increased by 48.12% in one year.
Market Cap
204.61B
Enterprise Value
210.38B
Revenue
56.32B
Global Rank
Country Rank
#373 India
PE Ratio
30.64
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 204.61B, an increase of 124,888.28%. That is a compound annual growth rate of 35.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 204.61B | 40.87% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 553.94B |
| GlaxoSmithKline Pharmaceuticals | 427.41B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 175.06B |
| Jubilant Pharmova | 148.59B |
| AstraZeneca Pharma India | 148.07B |
| Viyash Scientific | 98.55B |
| Procter & Gamble Health | 85.68B |